Agreed. We are bogged down in long and expensive

Agreed. We are bogged down in long and expensive trials (cancer, NASH, HIV) when sepsis could be fast and potentially well populated, thus cheaper. 1.7m @ 2k would go a long way.

I've noticed that sepsis is becoming relatively common in prosthesis patients with knee, shoulder, hip replacements.